Why is Kilitch Drugs falling/rising?

As of 14-Nov, Kilitch Drugs (India) Ltd is currently priced at 358.40, reflecting a decline of 9.7 points or 2.64%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 3.25% during this period. Today's trading saw the stock reach an intraday high of Rs 375.9 but also dip to a low of Rs 355. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 22.88% compared to the 5-day average, which may further contribute to the stock's downward movement. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's performance.
In the broader market context, Kilitch Drugs has underperformed relative to the Sensex, with a 1-week return of -5.81% compared to the benchmark's gain of 1.62%. Over the past month, the stock has shown a modest increase of 0.55%, while the Sensex has risen by 3.09%. Year-to-date, Kilitch Drugs has outperformed the benchmark with a return of 10.96% against the Sensex's 8.22%. However, the recent short-term declines suggest that the stock is struggling to maintain momentum, contrasting with its longer-term performance over 3 years and 5 years, where it has significantly outperformed the benchmark.